UK First for Middlewood Research Team

In a week which has shown the importance of medical research with the first Covid Vaccinations being given in the UK, we are delighted to announce another UK first for the Middlewood Research Team.

The 3rd December 2020 saw the global first recruitment day for ONWARDS1, investigating the effectiveness of the first once weekly insulin product, a potentially ground-breaking advance. The Middlewood Research Team screened the first UK patient on that day and are looking for at least 3 more to joint this hugely exciting global trial over the coming months.

Clinical Research Continues despite the Pandemic

Despite the restrictions of the COVID19 pandemic the Middlewood Clinical Research team have continued to manage their portfolio of Clinical Research studies and be as flexible as possible as regards study visit needs for our fantastic patient group who continue to contribute to this important part of healthcare. We have resumed recruitment to :
-SELECT : investigating the benefits of Semeglutide in patients with previous heart attack/stroke/vascular disease who are also overweight or obese.
-VESALIUS : investigating the benefits of evolocumab in patients at risk of first heart disease/stroke who have failed to reduce their cholesterol with other medications currently available

We are also still facilitating recruitment into the important PRINCIPLE COVID19 treatment trial in which the first patient recruited in Greater Manchester was a Middlewood patient

Click here to read more about our Research Team.